Search

Your search keyword '"Goebel J"' showing total 769 results

Search Constraints

Start Over You searched for: Author "Goebel J" Remove constraint Author: "Goebel J"
769 results on '"Goebel J"'

Search Results

351. A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study.

353. Post Paddle Boarding Atrial Fibrillation in an Aging Athlete.

354. Watchman Device Dislodgement Creating a Left Ventricular Outflow Tract Obstruction Requiring Emergency Cardiopulmonary Bypass.

355. Location, Location, Location: The Role of Objective Neighborhood Characteristics for Perceptions of Control.

356. Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities.

357. Job Satisfaction and Chronic Stress of General Practitioners and Their Teams: Baseline Data of a Cluster-Randomised Trial (IMPROVE job ).

358. Impact of once-daily ER-Tac on trough concentration variability in a stable AYA renal transplant recipient cohort.

359. COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative.

360. A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum.

361. Seroepidemiological study on the spread of SARS-CoV-2 in Germany: Study protocol of the CORONA-MONITORING bundesweit' study (RKI-SOEP study).

362. Management of dyslipidemia in pediatric renal transplant recipients.

363. Clinical Outcomes of Allogeneic Ocular Surface Stem Cell Transplantation in Pediatric Patients.

364. The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors.

365. Pediatric trichodysplasia spinulosa: A report of 2 cases and review of the literature.

366. Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models.

367. Is Histologic Thrombus Composition in Acute Stroke Linked to Stroke Etiology or to Interventional Parameters?

368. EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma.

369. Academic conferencing in the age of COVID-19 and climate crisis: The case of the Comparative and International Education Society (CIES).

370. Computer aided diagnosis for ASPECT rating: initial experiences with the Frontier ASPECT Score software.

372. Effectiveness of Endovascular Recanalization Treatment for M2 Segment Occlusion: Comparison Between Intracranial ICA, M1, and M2 Segment Thrombectomy.

373. Donor-specific antibodies in a pediatric kidney transplant population-Prevalence and association with antiproliferative drug dosing.

374. Bacterial contamination of automated MRI contrast injectors in clinical routine.

375. Tropospheric ozone and skin aging: Results from two German cohort studies.

376. Composite Health Outcomes in Pediatric and Young Adult Kidney Transplant Recipients.

377. Increase in chloride from baseline is independently associated with mortality in critically ill children.

378. Automated ASPECT rating: comparison between the Frontier ASPECT Score software and the Brainomix software.

379. Primary care in Germany: access and utilisation-a cross-sectional study with data from the German Socio-Economic Panel (SOEP).

380. Feasibility of aortic valve planimetry at 7 T ultrahigh field MRI: Comparison to aortic valve MRI at 3 T and 1.5 T.

381. COQ2 nephropathy: a treatable cause of nephrotic syndrome in children.

382. Doppler ultrasound triggering for cardiac MRI at 7T.

383. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.

384. Hyperchloremia is independently associated with mortality in critically ill children who ultimately require continuous renal replacement therapy.

385. Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17.

386. Adherence in pediatric kidney transplant recipients: solutions for the system.

387. OSSE Goes FAIR - Implementation of the FAIR Data Principles for an Open-Source Registry for Rare Diseases.

388. Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria.

389. Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs.

390. [Diagnostic criteria for Menière's disease according to the Classification Committee of the Bárány Society].

391. Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Transplantation: Results from Discrete Event Simulation.

392. In search of features that constitute an "enriched environment" in humans: Associations between geographical properties and brain structure.

393. Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.

394. Adrenal Incidentaloma and Subclinical Cushing's Syndrome: A Longitudinal Follow-Up Study by Endoscopic Ultrasound.

395. Real-time SPARSE-SENSE cine MR imaging in atrial fibrillation: a feasibility study.

396. New Nephrological Frontiers: Opportunities and Challenges Created by Fetal Care Centers.

397. Pediatric kidney transplantation.

398. "What else are you worried about?" - Integrating textual responses into quantitative social science research.

399. How does availability of county-level healthcare services shape terminal decline in well-being?

400. Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.

Catalog

Books, media, physical & digital resources